MAM
FOLD

Meeder Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Meeder Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-374
Closed -$4.41K – 895
2024
Q1 		$4.41K Buy
+374
New +$4.78K ﹤0.01% 647
2021
Q4 		– Sell
-1,400
Closed -$13K – 1592
2021
Q3 		$13K Buy
1,400
+1,331
+1,929% +$13.6K ﹤0.01% 1578
2021
Q2 		$1K Sell
69
-39
-36% -$381 ﹤0.01% 2336
2021
Q1 		$1K Buy
+108
New +$1.67K ﹤0.01% 2206
2020
Q4 		– Sell
-5,839
Closed -$83K – 1993
2020
Q3 		$83K Sell
5,839
-7,646
-57% -$111K 0.01% 832
2020
Q2 		$202K Buy
13,485
+11,627
+626% +$142K 0.01% 600
2020
Q1 		$17K Buy
+1,858
New +$17.7K ﹤0.01% 1305
2019
Q3 		– Sell
-5,852
Closed -$73K – 2178
2019
Q2 		$73K Buy
+5,852
New +$74.3K 0.01% 840
2017
Q4 		– Sell
-271
Closed -$4K – 1701
2017
Q3 		$4K Buy
+271
New +$3.58K ﹤0.01% 1318
2017
Q2 		– Sell
-1,313
Closed -$9K – 1722
2017
Q1 		$9K Sell
1,313
-3,553
-73% -$22.5K ﹤0.01% 871
2016
Q4 		$24K Sell
4,866
-675
-12% -$4.67K ﹤0.01% 629
2016
Q3 		$41K Buy
+5,541
New +$37.4K ﹤0.01% 656

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Meeder Asset Management's FOLD Position: Q2 2024 in Review

Meeder Asset Management sold out of Amicus Therapeutics (FOLD) in Q2 2024, closing a stake of 374 shares — an estimated $4.41K sold.

Meeder Asset Management first reported a position in FOLD in Q3 2016 and held it in 12 quarters. The position peaked at $202K in Q2 2020. 258 funds tracked by Wall St. Rank hold FOLD as of Q2 2024.

  • Meeder Asset Management reported no remaining Amicus Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Meeder Asset Management sold 374 Amicus Therapeutics shares in Q2 2024, an estimated $4.41K.
  • Meeder Asset Management first reported a position in Amicus Therapeutics in Q3 2016 and held it in 12 quarters.
  • Meeder Asset Management's Amicus Therapeutics position peaked at $202K in Q2 2020.
  • 258 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2024.

Based on Meeder Asset Management's 13F filing for Q2 2024, filed 8 Aug 2024.